An observational study in Peripheral Arterial Disease, Chronic Limb-Threatening Ischemia and Critical Limb Ischemia, sponsored by Medical University Innsbruck. Recruiting at 1 site in Austria. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-03-13.
Sponsored by Medical University Innsbruck · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 17 studies in Chronic Limb-Threatening Ischemia with a site in Austria — 3 open to participants now, 4 under way, none of them phase 3. Chronic Limb-Threatening Ischemia · Austria.
Among the 17 studies in Chronic Limb-Threatening Ischemia with a site in Austria, this one is the only one that started in 2022, is one of 3 observational ones, and was the 13th registered.
359 studies on the registry are indexed under Chronic Limb-Threatening Ischemia; 73 are open to participants now.
Browse Chronic Limb-Threatening Ischemia studies →3 of the 17 studies in Chronic Limb-Threatening Ischemia with a site in Austria are open now. Recruiting first, the newest first:
Medical University of Graz · Sites in Austria
Ages 18+
Stentit · Sites in Austria
Ages 18+
A study can be open while its sites in Austria have not opened yet or have stopped. Only those recruiting at a site in Austria →
Of the 51 Chronic Limb-Threatening Ischemia studies recruiting now, 35 (69%) set no upper age limit and 2 (4%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
17 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 1 started in 2022.
This study's planned enrollment of 200 is above the median of 111 across 104 observational studies indexed under Chronic Limb-Threatening Ischemia.
Median enrollment 67 across the 14 interventional studies, 200 across the 3 observational. Of the 9 that completed or were terminated, 4 (44%) have results posted.
This tab as a report to print or save as PDF → With an account.
11 of 17 have an industry lead sponsor. The 10 most frequent:
Medical University Innsbruck is the lead sponsor of 187 studies on the registry; 48 are open to participants now.
Medical University Innsbruck has 1 study filed under Chronic Limb-Threatening Ischemia — fewer than ten, so there is no comparison to draw.
1 of the studies in Chronic Limb-Threatening Ischemia with a site in Austria that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07465627Medical University of GrazVessel Recoil in Specific CLTI Populations | 2027-06 |
Add it to your calendar (.ics) → With an account.
Among the 17 studies in Chronic Limb-Threatening Ischemia with a site in Austria, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
In this prospective single-center observational study, arterial perfusion in patients with lower limb peripheral arterial disease will be assessed with standard diagnostic tools (toe pressure, trans-cutaneous oxygen pressure, ankle-brachial index and fluorescence angiography) before and after standard revascularization procedures (open surgery and/or angioplasty).
Arterial perfusion is an important parameter for the capacity of wound healing in patients with peripheral arterial disease (PAD). Quantifying tissue perfusion in affected patients can help in deciding whether further revascularization is necessary to achieve wound healing and limb salvage. Not only in PAD patients with ulceration, but also in patients with rest pain or life-style limiting claudication, the measurement of arterial perfusion before and after revascularization could influence further treatment regarding surgical/interventional procedures as well as medical treatment. Digital subtraction angiography (DSA) is the gold standard for the evaluation of peripheral arterial outflow and for quality assessment after revascularization. However, angiography only displays the larger arteries and not tissue perfusion itself, which is crucial for wound healing. In this study, the change of tissue perfusion measured with the different standard diagnostic tools (toe pressure, trans-cutaneous oxygen pressure, ankle-brachial index and fluorescence angiography) before and after standard revascularization procedures will be evaluated.
359 studies on the registry are indexed under Chronic Limb-Threatening Ischemia; 73 are open to participants now.
This study's planned enrollment of 200 is above the median of 111 across 104 observational studies indexed under Chronic Limb-Threatening Ischemia.
Browse Chronic Limb-Threatening Ischemia studies →Medical University Innsbruck is the lead sponsor of 187 studies on the registry; 48 are open to participants now.
Compared within Chronic Limb-Threatening Ischemia, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Peripheral Arterial Disease. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Patients with symptomatic peripheral arterial disease (Rutherford categories 3-6) requiring revascularization procedures (open surgery and/or angioplasty).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
GFR and eGFR (kidney filtering)
GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².
Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Open surgery (arterial endarterectomy with or without bypass surgery) and/or angioplasty (with or without stent placement)
Transcutaneous oxygen pressure
Change in transcutaneous oxygen pressure is measured before and after the revascularization procedure.
Time frame: Pre-procedural, post-procedural (within 5 days) and 3 months after the index procedure
WIfI stage
Change in WIfI (wound, ischemia, foot infection) stage is documented before and after the revascularization procedure.
Time frame: Pre-procedural, post-procedural (within 5 days) and 3 months after the index procedure
Rutherford category
Change in Rutherford category is documented before and after the revascularization procedure.
Time frame: Pre-procedural, post-procedural (within 5 days) and 3 months after the index procedure
Primary patency
Primary patency of the treated arterial lesion is documented after the procedure
Time frame: Post-procedural (within 5 days) and 3 months after the index procedure
Secondary patency
Secondary patency of the treated arterial lesion is documented after the procedure
Time frame: Post-procedural (within 5 days) and 3 months after the index procedure
Limb salvage
Limb salvage of the treated extremity is documented after the procedure
Time frame: Post-procedural (within 5 days) and 3 months after the index procedure
Ankle-brachial index (ABI)
Change in ABI is documented before and after the revascularization procedure.
Time frame: Pre-procedural, post-procedural (within 5 days) and 3 months after the index procedure
Fluorescence angiography
Change in fluorescence angiography is documented before and after the revascularization procedure.
Time frame: Pre-procedural, post-procedural (within 5 days) and 3 months after the index procedure
Survival
Survival of patients after the revascularization.
Time frame: Post-procedural (within 5 days) and 3 months after the index procedure
Plan to share: No
Started Oct 2022 (actual). Primary completion is estimated for Sep 2024, 23 months after the start.
Of 47 non-industry observational studies under Chronic Limb-Threatening Ischemia, half reached primary completion within 35 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 60. This study's planned 23 months is below that.
Counting every sponsor, half of 53 studies reached it within 34 months; a quarter within 22 and three quarters within 59.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chronic Limb-Threatening Ischemia →
Medical University Innsbruck →